NCI Drug Dictionary

The NCI Drug Dictionary contains technical definitions and synonyms for drugs/agents used to treat patients with cancer or conditions related to cancer. Each drug entry includes links to check for clinical trials listed in NCI's List of Cancer Clinical Trials.

Browse:
CD3+/CD19+ cell-depleted unrelated or partially matched donor-derived allogeneic peripheral blood stem cells
A preparation of allogeneic peripheral blood stem cells (PBSCs) from an unrelated or partially matched related donor that have been selectively depleted of CD3-positive (CD3+) T cells and CD19-positive (CD19+) B cells via leukapheresis with potential immune reconstituting activity. The CD3+/CD19+ cell-depleted PBSCs are used for allogeneic hematopoietic cell transplantation (HCT) and may allow for rapid and sustained engraftment, immune reconstitution, and may prevent or reduce graft-versus-host disease (GvHD) and Epstein-Barr virus (EBV)-driven post-transplant lymphoproliferative disorders. Check for active clinical trials using this agent. (NCI Thesaurus)

Synonym:CD3+ and CD19+ cell-depleted allogeneic PBSCs derived from an unrelated or partially matched donor
CD3+ T-cell-depleted/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic peripheral blood stem cells
CD3+/CD19+ cell-depleted unrelated or partially matched donor-derived allogeneic PBSCs